Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The spreading of pathology within and between brain areas is a hallmark of neurodegenerative disorders. In patients with Alzheimer’s disease, deposition of amyloid-β is accompanied by activation of the innate immune system and involves inflammasome-dependent formation of ASC specks in microglia. ASC specks released by microglia bind rapidly to amyloid-β and increase the formation of amyloid-β oligomers and aggregates, acting as an inflammation-driven cross-seed for amyloid-β pathology. Here we show that intrahippocampal injection of ASC specks resulted in spreading of amyloid-β pathology in transgenic double-mutant APPSwePSEN1dE9 mice. By contrast, homogenates from brains of APPSwePSEN1dE9 mice failed to induce seeding and spreading of amyloid-β pathology in ASC-deficient APPSwePSEN1dE9 mice. Moreover, co-application of an anti-ASC antibody blocked the increase in amyloid-β pathology in APPSwePSEN1dE9 mice. These findings support the concept that inflammasome activation is connected to seeding and spreading of amyloid-β pathology in patients with Alzheimer’s disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-1 beta was shown to exacerbate tau pathologies [97] and reduce microglial phagocytic activity [92,93,94].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [94]
In the citing paper
“Rat research has identified the NLRP3-ASC inflammasome as a major mechanism through which microglia may drive pathological features of AD [92,93,94].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [94]
In the citing paper
“In turn, the NLRP3 inflammasome is essential for the development and progression of Aβ pathology in mice29 and may drive tau pathology through Aβ-induced microglial activation30.”
From New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) · cites this paper as [29]
In the citing paper
“Pyroptosis of glial cells leads to release of ASC specks into the extracellular space, where it binds rapidly to Aβ peptides, increasing the aggregation of Aβ.357”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [357]
In the citing paper
“In that study, ASC-bound Aβ was detected in brain samples from AD patients, but not in samples from age-matched controls without dementia.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [80]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Self-citationScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Self-citationUnified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Lu, A., Magupalli, V. G., Ruan, J., Yin, Q., Atianand, M. K., Vos, M. R., Schröder, G. F., Fitzgerald, K. A., Wu, H., & Egelman, E. H. (2014) · Cell · doi:10.1016/j.cell.2014.02.008 · Cited by 1,353
Cited by
Items 301–400 of 1,002
The NLRP3 inflammasome: a new player in neurological diseases
Eren, E., & Özören, N. (2019) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1909-31 · Cited by 56
“Similarly, in AD, ASC specks are secreted from microglia, bind to Aβ, increase their oligomerization, and facilitate their propagation in different areas of the brain (Venegas et al, 2017).”
BackgroundInfluentialZhang, L., Liu, X., Liu, D., Yu, X., Zhang, L., Zhu, J., Lu, S., & Liu, R. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910691 · Cited by 51
The role of glia in protein aggregation
Li, Q., & Haney, M. S. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105015 · Cited by 52
“These extracellular ASC specks may propagate the wave of inflammation in the CNS as well as cross-seed Aβ aggregate formation (Venegas et al., 2017).”
BackgroundBAD-mediated neuronal apoptosis and neuroinflammation contribute to Alzheimer's disease pathology
Zhang, L., Qian, Y., Li, J., Zhou, X., Xu, H. J., Yan, J., Xiang, J., Yuan, X., Sun, B., Sisodia, S. S., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102942 · Cited by 57
The behavior and functions of embryonic microglia
Hattori, Y. (2021) · Anatomical Science International · doi:10.1007/s12565-021-00631-w · Cited by 55
He, S., Li, L., Chen, H., Hu, X., Wang, W., Zhang, H., Wei, R., Zhang, X., Chen, Y., & Liu, X. (2022) · Journal of Virology · doi:10.1128/jvi.02127-21 · Cited by 55
Inflammasome Activation in Parkinson’s Disease
Jewell, S. L., Herath, A. M., & Gordon, R. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223338 · Cited by 61
“Ground-breaking studies in AD have demonstrated that extracellular inflammasome components such as prionoid ASC can indeed cross-seed and propagate misfolded pathological proteins and thereby drive neuropathology [11].”
BackgroundPyroptosis and the cellular consequences of gasdermin pores
Huston, H. C., Anderson, M. J., & Fink, S. L. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101803 · Cited by 58
NLRP3 inflammasome in Alzheimer’s disease: molecular mechanisms and emerging therapies
Li, Z., & Gong, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1583886 · Cited by 73
“As AD progresses, chronic NLRP3 activation leads to excessive microglial activation, diminishing their ability to clear A b and fostering its accumulation (18, 19).”
Beneficial Effects of Citrus-Derived Polymethoxylated Flavones for Central Nervous System Disorders
Matsuzaki, K., & Ohizumi, Y. (2021) · Nutrients · doi:10.3390/nu13010145 · Cited by 55
“(2017) reported that the overactivation of microglia in the brain elicits an inflammatory response that triggers Aβ accumulation [9].”
BackgroundCodocedo, J. F., Mera-Reina, C., Bor-Chian Lin, P., Fallen, P. B., Puntambekar, S. S., Casali, B. T., Jury-Garfe, N., Martinez, P., Lasagna-Reeves, C. A., & Landreth, G. E. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114488 · Cited by 52
“49 In addition, the production of proinflammatory factors that act to remodel synapses by altering their shape, composition, and density ultimately contributes to the cognitive dysfunction of AD patients 50 (Figure 7A).”
Tipping points in neurodegeneration
Simons, M., Levin, J., & Dichgans, M. (2023) · Neuron · doi:10.1016/j.neuron.2023.05.031 · Cited by 50
“Chronic inflammatory activation of microglia can lead to pyroptosis, which results in the release of apoptosis-associated speck-like proteins, which can act as seeds for Ab deposition and thereby causing spread of pathology.(140) Inflammasomeactivated microglia can also influence neuronal tau pathology.”
Mehrzad, J., Hosseinkhani, S., & Malvandi, A. M. (2018) · NeuroImmunoModulation · doi:10.1159/000493528 · Cited by 52
Cao, X., Xu, H., Feng, W., Su, D., & Xiao, M. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.007 · Cited by 52
Glial AP1 is activated with aging and accelerated by traumatic brain injury
Byrns, C. N., Saikumar, J., & Bonini, N. M. (2021) · Nature Aging · doi:10.1038/s43587-021-00072-0 · Cited by 49
ASC specks exacerbate α‑synuclein pathology via amplifying NLRP3 inflammasome activities
Zheng, R., Yan, Y., Dai, S., Ruan, Y., Chen, Y., Hu, C., Lin, Z., Xue, N., Song, Z., Liu, Y. F., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02709-w · Cited by 54
“Studies on AD have shown that ASC expressions increase with age in APP/PS1, but not in wild‐type mice [59, 60].”
BackgroundMethodRegulated cell death and its role in Alzheimer’s disease and amyotrophic lateral sclerosis
Thal, D. R., Gawor, K., & Moonen, S. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02722-0 · Cited by 51
Microglia and gut microbiota: A double-edged sword in Alzheimer's disease
Bano, N., Khan, S., Ahamad, S., Kanshana, J. S., Dar, N. J., Khan, S. J., Nazir, A., & Bhat, S. A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102515 · Cited by 53
Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
Fuster-Matanzo, A., Hernández, F., & Ávila, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030645 · Cited by 52
“Interestingly, recently, work published by Venegas et al. has established a direct correlation between the microglia-dependent inflammasome activity and the spreading of amyloid-β pathology in AD [109].”
BackgroundMetzler‐Baddeley, C., Mole, J. P., Sims, R., Fasano, F., Evans, J., Jones, D. K., Aggleton, J. P., & Baddeley, R. (2019) · Scientific Reports · doi:10.1038/s41598-018-37658-5 · Cited by 54
Extracellular ASC exacerbated the recurrent ischemic stroke in an NLRP3-dependent manner
He, X., Zeng, Y., Li, G., Feng, Y.-K., Wu, C., Liang, F., Zhang, Y., Lan, Y., Xu, G., & Pei, Z. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19856226 · Cited by 54
Systemic inflammation as a central player in the initiation and development of Alzheimer’s disease
Bayraktaroğlu, I., Ortí-Casañ, N., Dam, D. V., Deyn, P. P. D., & Eisel, U. L. M. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00529-5 · Cited by 54
Transient microglial absence assists postmigratory cortical neurons in proper differentiation
Hattori, Y., Naito, Y., Tsugawa, Y., Nonaka, S., Wake, H., Nagasawa, T., Kawaguchi, A., & Miyata, T. (2020) · Nature Communications · doi:10.1038/s41467-020-15409-3 · Cited by 55
Pellegrini, C., Daniele, S., Antonioli, L., Benvenuti, L., D’Antongiovanni, V., Piccarducci, R., Pietrobono, D., Citi, V., Piragine, E., Flori, L., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103523 · Cited by 51
“Interestingly, a similar picture has been observed in brain tissues from AD mice, where NLRP3 activation and Aβ protein deposition, mitochondrial dysfunction, and IL-1βwere detected [38].”
BackgroundGao, C., Shen, X., Tan, Y., & Chen, S. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02580-1 · Cited by 52
Small-molecule theranostics in Alzheimer's disease
Sarabia‐Vallejo, Á., López‐Alvarado, P., & Menéndez, J. C. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115382 · Cited by 52
Du, B., Zou, Q., Wang, X., Wang, H., Yang, X., Wang, Q., & Wang, K. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123403 · Cited by 53
Gargouri, B., Yousif, N. M., Bouchard, M., Fetoui, H., & Fiebich, B. L. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1198-1 · Cited by 52
Ibrahim, W. W., Skalicka‐Woźniak, K., Budzyńska, B., & Sayed, N. S. E. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110239 · Cited by 49
Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer
Zhu, X., Bao, Y., Guo, Y., & Yang, W. (2018) · Cancers · doi:10.3390/cancers10050139 · Cited by 48
“This finding is supported by an experiment in the transgenic double-mutant APPSwePSEN1dE9 mouse model, in which intrahippocampal injection of ASC specks resulted in spreading of amyloid-β, and administration of anti-ASC antibody abrogated amyloid-β accumulation and pathology [40].”
BackgroundResultWang, Y., Guan, X., Chen, X., Cai, Y., Ma, Y., Ma, J., Zhang, Q., Dai, L., Fan, X., & Bai, Y. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801407 · Cited by 50
Liu, J., Zhang, X., & Wang, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113680 · Cited by 49
TGR5 deficiency in excitatory neurons ameliorates Alzheimer’s pathology by regulating APP processing
Li, C., Wang, L., Xie, W., Chen, E., Chen, Y., Li, H., Can, D., Lei, A., Wang, Y., & Zhang, J. (2024) · Science Advances · doi:10.1126/sciadv.ado1855 · Cited by 57
“…and microglia exacerbated the propagation of β - amyloid plaques by triggering the NLRP3 inflammasome and releasing of apoptosis-associated speck-like protein containing a C-terminal caspase recruitment domain (ASC specks), which quickly bind and cross-seed A β peptides extracellularly ( 41 ).”
BackgroundInflammasome-Mediated Neuroinflammation: A Key Driver in Alzheimer’s Disease Pathogenesis
McGroarty, J., Salinas, S., Evans, H., Jimenez, B., Tran, V., Kadavakollu, S., Vashist, A., & Atluri, V. S. R. (2025) · Biomolecules · doi:10.3390/biom15050676 · Cited by 51
“During cell death, more ASC adaptor proteins are released, leading to a continued cycle of composite formations and NLRP3 activity, further impairing microglial cell ability for clearance and progressing AD [35–37].”
Ye, A., Li, W., Zhou, L., Ao, L., Fang, W., & Li, Y. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.10.009 · Cited by 50
Azam, S., Haque, M. E., Kim, I., & Choi, D. (2021) · Cells · doi:10.3390/cells10010150 · Cited by 51
“Therefore, microglia approach the neuroinflammatory threshold by producing peripheral inflammatory cytokines such as TNF-α and IL-1β [33,34].”
BackgroundInfluentialNanobodies dismantle post‐pyroptotic ASC specks and counteract inflammation in vivo
Bertheloot, D., Wanderley, C. W. S., Schneider, A. H., Schiffelers, L. D. J., Wuerth, J. D., Tödtmann, J. M. P., Maasewerd, S., Hawwari, I., Duthie, F., Rohland, C., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202115415 · Cited by 49
“ASC is an interesting therapeutic target as it plays a central role in inflammasome activation, but also displays inflammasome-independent functions (Ellebedy et al , 2011; Guo & Dhodapkar, 2012; Tsuchiya et al , 2014; Franklin et al , 2017; Venegas et al , 2017; Friker et al , 2020).”
InfluentialSelf-citationThe microglial lysosomal system in Alzheimer’s disease: Guardian against proteinopathy
Van Acker, Z. P., Perdok, A., Bretou, M., & Annaert, W. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101444 · Cited by 45
Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders
Golde, T. E. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.027 · Cited by 45
Lemche, E., Killick, R., Mitchell, J., Caton, P., Choudhary, P., & Howard, J. K. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106485 · Cited by 54
Genetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
Takatori, S., Wang, W., Iguchi, A., & Tomita, T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-05542-4_5 · Cited by 44
The therapeutic potential of bone marrow‐derived macrophages in neurological diseases
Zhou, K., Han, J., Wang, Y., Xu, Y., Zhang, Y., & Zhu, C. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13964 · Cited by 47
The multifaceted roles of embryonic microglia in the developing brain
Hattori, Y. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.988952 · Cited by 45
“Microglia were once mainly assumed to function in pathological states, such as aging, chronic stress, and Alzheimer’s disease, by mediating neuroinflammatory processes (Tynan et al., 2010; Venegas et al., 2017; Streit et al., 2020).”
BackgroundImmune modulation to treat Alzheimer’s disease
Duggan, M. R., Morgan, D., Price, B. R., Rajbanshi, B., Martín‐Peña, A., Tansey, M. G., & Walker, K. A. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00828-x · Cited by 49
Innate Immunity and Cell Death in Alzheimer’s Disease
Lee, S., Cho, H.-J., & Ryu, J.-H. (2021) · ASN Neuro · doi:10.1177/17590914211051908 · Cited by 45
Flores, J., Fillion, M.-L., & LeBlanc, A. C. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05290-x · Cited by 46
Ferguson, C. M., Hildebrand, S., Godinho, B. M. D. C., Buchwald, J., Echeverria, D., Coles, A., Grigorenko, A., Vangjeli, L., Sousa, J., McHugh, N., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13703 · Cited by 37
Self-citationA role for microglia in mediating the microbiota–gut–brain axis
Keane, L., Clarke, G. A., & Cryan, J. F. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01188-9 · Cited by 48
Is ‘friendly fire’ in the brain provoking Alzheimer’s disease?
Abbott, A. (2018) · Nature · doi:10.1038/d41586-018-04930-7 · Cited by 45
NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration
Sita, G., Graziosi, A., Hrelia, P., & Morroni, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136984 · Cited by 38
“ROS formation and cellular homeostasis are fundamental for the NLRP3 inflammasome activation, as potassium (K+) or calcium (Ca2+) efflux or influx are established activators that lead to mitochondria damage and ROS formation, potentiating the NLRP3 inflammasome activation [72–74].”
BackgroundInfluentialKlotho an Autophagy Stimulator as a Potential Therapeutic Target for Alzheimer’s Disease: A Review
Fung, T., Iyaswamy, A., Sreenivasmurthy, S. G., Krishnamoorthi, S., Guan, X.-J., Zhu, Z., Su, C.-F., Liu, J., Kan, Y., Zhang, Y., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10030705 · Cited by 49
“A high concentration of NLRP3, ASC and active caspase-1, has been shown in APP/PS1 transgenic mice [35,97].”
BackgroundAli, J., Choe, K., Park, J. S., Park, H. Y., Kang, H., Park, T. J., & Kim, M.-O. (2024) · Antioxidants · doi:10.3390/antiox13070862 · Cited by 44
Albornoz, E. A., Woodruff, T. M., & Gordon, R. (2018) · Experientia supplementum · doi:10.1007/978-3-319-89390-7_3 · Cited by 47
Westfall, S., Iqbal, U., Sebastian, M., & Pasinetti, G. M. (2019) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2019.06.013 · Cited by 41
Neuroinflammation of Microglial Regulation in Alzheimer’s Disease: Therapeutic Approaches
Chen, H., Zeng, Y., Wang, D., Li, Y., Xing, J., Zeng, Y., Liu, Z., Zhou, X., & Fan, H. J. (2024) · Molecules · doi:10.3390/molecules29071478 · Cited by 46
ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseases
Lobanova, E., Zhang, Y. P., Emin, D., Brelstaff, J., Kahanawita, L., Malpetti, M., Quaegebeur, A., Triantafilou, K., Triantafilou, M., Zetterberg, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53547-0 · Cited by 43
“During in fl ammasome activation ASC rapidly assembles into a large protein complex, up to 1 µ m in size, termed the ‘ speck ’ which can, ultimately, be lost from the cell when it ruptures 22 .”
Neuroinflammation in Age-Related Neurodegenerative Diseases: Role of Mitochondrial Oxidative Stress
Abadin, X., de Dios, C., Zubillaga, M., Ivars, E., Puigròs, M., Marí, M., Morales, A., Vizuete, M., Vitórica, J., Trullás, R., et al. (2024) · Antioxidants · doi:10.3390/antiox13121440 · Cited by 47
Aβ Seeding as a Tool to Study Cerebral Amyloidosis and Associated Pathology
Friesen, M., & Meyer‐Luehmann, M. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00233 · Cited by 44
“Finally, in vivo seeding as a model can assist to identify factors impacting or accelerating AD progression such as microgliaderived ASC specks (Venegas et al., 2017) or the Trem2 receptor”
BackgroundMicrobiota in cerebrovascular disease: A key player and future therapeutic target
Tonomura, S., Ihara, M., & Friedland, R. P. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20918031 · Cited by 43
Kumar, S., Budhathoki, S., Oliveira, C. B., Kahle, A. D., Calhan, O. Y., Lukens, J. R., & Deppmann, C. D. (2023) · JCI Insight · doi:10.1172/jci.insight.157433 · Cited by 39
“How precisely might caspase-8 influence the spread of AD pathology? Protein aggregates such as Aβ and tau can activate the NLRP3 inflammasome (28, 29, 31), the components of which are predominantly expressed by astrocytes and microglia in the CNS (67, 68).”
BackgroundSelf-citationWang, G., Yin, W., Shin, H., Tian, Q., Lü, W., & Hou, X. S. (2021) · Nature Aging · doi:10.1038/s43587-021-00130-7 · Cited by 42
Wu, M., Cheng, Y., Zhang, R., Han, W., Jiang, H., Bi, C., Zhang, Z., Ye, M., Lin, X., & Liu, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117228 · Cited by 41
A2AR‐induced transcriptional deregulation in astrocytes: An in vitro study
Paiva, I., Carvalho, K., Santos, P. I., Cellai, L., Pavlou, M. A. S., Jain, G., Gnad, T., Pfeifer, A., Vieau, D., Fischer, A., et al. (2019) · Glia · doi:10.1002/glia.23688 · Cited by 42
“The benefit afforded by inhibition of the NLRP3 or IL1ß signaling cascades in AD mouse models (Kitazawa et al., 2011; Heneka et al., 2013; Venegas et al., 2017) would be therefore prone to block a detrimental A2AR-mediated effect on IL1ß production by microglial and astrocytic cells.”
BackgroundLlibre‐Guerra, J. J., Li, Y., Schindler, S. E., Gordon, B. A., Fagan, A. M., Morris, J. C., Benzinger, T. L. S., Hassenstab, J. J., Wang, G., Allegri, R., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.17126 · Cited by 42
Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
Biber, K., Bhattacharya, A., Campbell, B. M., Piro, J. R., Rohe, M., Staal, R. G. W., Talanian, R. V., & Möller, T. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00840 · Cited by 42
Unknown/enigmatic functions of extracellular ASC
de Souza, J. G., Starobinas, N., & Ibañez, O. M. (2021) · Immunology · doi:10.1111/imm.13375 · Cited by 48
The Potential of NLRP3 Inflammasome as a Therapeutic Target in Neurological Diseases
He, W., Hu, Z., Zhong, Y., Wu, C., & Li, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03229-7 · Cited by 41
Bhat, M. A., Ahmad, K., Khan, M. S., Bhat, M. A., Almatroudi, A., Rahman, S., & Jan, A. T. (2020) · Biomolecules · doi:10.3390/biom10060863 · Cited by 44
“Simultaneously, activation of the microglial NLRP3 inflammasome enhances Aβ aggregation and its spread, thereby creating a feedback loop that exacerbates neuronal cell death [81].”
BackgroundMicroglia in Alzheimer’s Disease: An Unprecedented Opportunity as Prospective Drug Target
Kulkarni, B., Martins, N. A., & Kumar, D. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02661-x · Cited by 39
Fang, Z., Luo, Y., Ma, C., Li, D., & Chen, F. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7340881 · Cited by 42
“In addition, because of the inhibitory e ff ects on microglial activation, polyphenols may restrain the release of microglia-derived ASC specks, further decreasing the A β oligomer formation and aggression [53, 54].”
McKee, C., Hoffos, M., Vecchiarelli, H. A., & Tremblay, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1125982 · Cited by 40
“Apoptosis-associated speck-like protein containing a CARD (ASC) is produced by microglia and is a central adaptor protein of NLRP3 that binds to Aβ and aids in the formation of Aβ oligomers (Venegas et al., 2017).”
BackgroundMaran, J. J., Adesina, M. M., Green, C. R., Kwakowsky, A., & Mugisho, O. O. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101954 · Cited by 40
Gebril, H. M., Aryasomayajula, A., de Lima, M. R. N., Uhrich, K. E., & Moghe, P. V. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-023-00393-7 · Cited by 40
“In line with this notion, activated microglia have been linked to Aβ seeding and plaque growth [23–25].”
BackgroundBadr, A., Daily, K. P., Eltobgy, M. M., Estfanous, S. Z. K., Tan, M. H., Kuo, J. C., Whitham, O. D., Carafice, C., Gupta, G., Amer, H. M., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.05.006 · Cited by 39
“AD microglia release ASC specks, which act as seeds for A β fibrils to form oligomers and aggregates (Venegas et al., 2017).”
InfluentialEskandari‐Sedighi, G., Crichton, M. C., Zia, S., Gomez‐Cardona, E., Cortez, L. M., Patel, Z. H., Takahashi, K., Laurent, C. D. S., Sidhu, G., Sarkar, S., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00734-8 · Cited by 38
“Phagocytic clearance of small and intermediate Aβ assemblies can modify plaque composition in numerous ways such as discarding diffused Aβ that extend from the plaque core [46, 47, 99].”
BackgroundMethodMiyazawa, K., Fukunaga, H., Tatewaki, Y., Takano, Y., Yamamoto, S., Mutoh, T., & Taki, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165783 · Cited by 37
Xu, Z., Liu, C., Wang, R., Gao, X.-R., Hao, C., & Liu, C. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108558 · Cited by 38
Microglia in Neurodegenerative Events—An Initiator or a Significant Other?
Harry, G. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115818 · Cited by 40
“These factors can act on adjacent cells to activate the NF-κB signal pathway, alter lysosome integrity, and enhance or prolong the immune response [97].”
BackgroundInflammasome activation in neurodegenerative diseases
Ravichandran, K. A., & Heneka, M. T. (2021) · Essays in Biochemistry · doi:10.1042/ebc20210021 · Cited by 38
Self-citationNakajo, T., Katayoshi, T., Kitajima, N., & Tsuji, K. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102203 · Cited by 38
“Aberrant inflammasome activation has been linked to cancer, and autoimmune and neurodegenerative diseases [40,41].”
BackgroundFengler, S., Kurkowsky, B., Kaushalya, S. K., Roth, W., Fava, E., & Denner, P. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121525 · Cited by 40
Research Progress of Pyroptosis in Alzheimer’s Disease
Xue, W., Cui, D., & Qiu, Y. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.872471 · Cited by 46
Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
Huang, Y., Li, X., Luo, G., Wang, J., Li, R., Zhou, C., Wan, T., & Yang, F. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.996646 · Cited by 37
The microglia-blood vessel interactions in the developing brain
Hattori, Y. (2022) · Neuroscience Research · doi:10.1016/j.neures.2022.09.006 · Cited by 38
“Microglia were initially identified as innate immune sentinels at the front line to defend against foreign pathogens and injury-related agents (Ajami et al., 2018; Perry et al., 2010; Picard et al., 2021; Streit et al., 1988; Venegas et al., 2017).”
BackgroundDysfunctional microglia and tau pathology in Alzheimer’s disease
Ayyubova, G. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0087 · Cited by 35
Doroszkiewicz, J., Mroczko, J., Winkel, I., & Mroczko, B. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175057 · Cited by 42
“Chronically activated microglia and astrocytes can induce brain damage by promoting the formation of toxic protein aggregates and increasing the susceptibility of neurons to cell death through the continuous release of pro-inflammatory cytokines [6,7].”
BackgroundSingle-cell RNA sequencing reveals peripheral immunological features in Parkinson’s Disease
Xiong, L., Du, R., Niu, R., Xue, L., Chen, L., Huangfu, L., Cai, X.-X., He, X., Huang, J., Huang, X., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00790-3 · Cited by 37
Electronic versus Combustible Cigarette Effects on Inflammasome Component Release into Human Lung
Tsai, M., Song, M., McAndrew, C. C., Brasky, T. M., Freudenheim, J. L., Mathé, E. A., McElroy, J. P., Reisinger, S. A., Shields, P. G., & Wewers, M. D. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201808-1467le · Cited by 37
Kartalou, G.-I., Pereira, A. R. S., Endres, T., Lesnikova, A., Casarotto, P. C., Pousinha, P. A., Delanoe, K., Edelmann, E., Ċastrén, E., Gottmann, K., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238957 · Cited by 37
“In addition, reduced levels of microglia-derived ASC specks proteins, which have recently been shown to increase Aβ plaque formation [25], might contribute to fingolimod induced rescue of synaptic functions in APP/PS1 mice.”
BackgroundGuerville, F., Vialemaringe, M., Cognet, C., Duffau, P., Lazaro, E., Cazanave, C., Bonnet, F., Leleux, O., Rossignol, R., Pinson, B., et al. (2023) · AIDS · doi:10.1097/qad.0000000000003546 · Cited by 37
Kopeć, K., Szleszkowski, S., Koziorowski, D., & Szlufik, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210366 · Cited by 43
Specialized functions of resident macrophages in brain and heart
Nicolás-Ávila, J. Á., Hidalgo, A., & Ballesteros, I. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.6mr0118-041r · Cited by 37
Zhou, L., Flores, J., Noël, A., Beauchet, O., Sjöström, P. J., & LeBlanc, A. C. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0856-6 · Cited by 37
Feng, D., Guo, L., Liu, J., Song, Y., Ma, X., Hu, H., Liu, J., & Hao, E. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10825 · Cited by 39
The Role of Non-canonical and Canonical Inflammasomes in Inflammaging
Cyr, B. S., Hadad, R., Keane, R. W., & Vaccari, J. P. D. R. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.774014 · Cited by 36
COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
Baazaoui, N., & Iqbal, K. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220105 · Cited by 37
Španić, E., Langer Horvat, L., Ilić, K., Hof, P. R., & Šimić, G. (2022) · Cells · doi:10.3390/cells11142223 · Cited by 35
SIRT2 as a potential new therapeutic target for Alzheimer’s disease
Sola-Sevilla, N., & Puerta, E. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.375315 · Cited by 36
“In addition, ASC specks can be visualized in brain sections of patients with AD and APP/PS1 mice (Venegas et al., 2017).”
Characterizing microglial senescence: Tau as a key player
Karabag, D., Scheiblich, H., Griep, A., Santarelli, F., Schwartz, S., Heneka, M. T., & Ising, C. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15866 · Cited by 38
“Primary wildtype mouse microglia cell cultures were prepared as previously described (Venegas et al., 2017).”
MethodSelf-citationRedondo‐Castro, E., Faust, D., Fox, S. G., Baldwin, A. G., Osborne, S. A., Haley, M., Karran, E. H., Nuthall, H. N., Atkinson, P. J., Dawson, L. A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24029-3 · Cited by 37
Metadata
- Authors
- Venegas, C., Kumar, S., Franklin, B. S., Dierkes, T., Brinkschulte, R., Tejera, D., Vieira-Saecker, A., Schwartz, S., Santarelli, F., Kummer, M. P., Griep, A., Gelpi, E., Beilharz, M., Riedel, D., Golenbock, D. T., Geyer, M., Walter, J., Latz, E., & Heneka, M. T.
- Affiliations
- University of Bonn (DE)
- Max Planck Institute for Biophysical Chemistry (DE)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Heneka, Michael T.
- ORCID
- Venue
- Nature
- Published
- 2017-12
- Volume
- 552
- Issue
- 7685
- Pages
- 355-361
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2777928756
- Semantic Scholar
- cb17ef0ab08a09442fa73b451fad4635f8d4ab3b
- Cited by
- 983
- References
- 33
- Citations by year
- 2026: 90 · 2025: 112 · 2024: 135 · 2023: 129 · 2022: 130 · 2021: 129 · 2020: 108 · 2019: 81 · 2018: 64 · 2017: 1
- FWCI
- 51.62
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by-nc-nd)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- Alzheimer's disease, amyloid-beta, ASC specks, microglia, inflammasome, cross-seeding, amyloid-beta oligomers, innate immunity, neuroinflammation, amyloid-beta aggregation
- MeSH terms
- Protein Domains, Alzheimer Disease, Animals, Antibodies, Female, Hippocampus, Humans, Inflammation, Mice, Inbred C57BL, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Microglia, Mice, Knockout, Mice, CARD Signaling Adaptor Proteins, Presenilin-1, Inflammasomes, Spatial Memory, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.